We are live on ! Find out more
SG

StoneX Group Portfolio holdings

AUM $1.86B
1-Year Est. Return 21.3%
This Fund
S&P 500
This Quarter Est. Return
+7.57%
1 Year Est. Return
+21.3%
3 Year Est. Return
+67.54%
5 Year Est. Return
+78.7%
10 Year Est. Return
–
AUM
$687M
AUM Growth
+$150M
Cap. Flow
+$115M
Cap. Flow %
16.76%
Top 10 Hldgs %
38.7%
Holding
678
New
317
Increased
139
Reduced
121
Closed
86

Top Buys

Rank Stock Value
1
IWR icon
iShares Russell Mid-Cap ETF
IWR
+$12.3M
2
IVV icon
iShares Core S&P 500 ETF
IVV
+$10.8M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$9.48M
4
EEM icon
iShares MSCI Emerging Markets ETF
EEM
+$6.88M
5
SHY icon
iShares 1-3 Year Treasury Bond ETF
SHY
+$3.52M

Top Sells

Rank Stock Value
1
MGK icon
Vanguard Mega Cap Growth ETF
MGK
+$4.64M
2
MGC icon
Vanguard Mega Cap 300 Index ETF
MGC
+$3.72M
3
VXF icon
Vanguard Extended Market ETF
VXF
+$2.7M
4
ITOT icon
iShares Core S&P Total US Stock Market ETF
ITOT
+$2.51M
5
IEMG icon
iShares Core MSCI Emerging Markets ETF
IEMG
+$2.31M

Sector Composition

Rank Sector Weight
1 Healthcare 1.9%
2 Industrials 1.84%
3 Financials 1.61%
4 Energy 1.31%
5 Technology 1.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITRG
476
Integra Resources
ITRG
$438M
$6.8K ﹤0.01%
+4,295
New +$6.66K
KEEL
477
Keel Infrastructure Corp
KEEL
$2.57B
$6.6K ﹤0.01%
+14,998
New +$11K
ALZN icon
478
Alzamend Neuro
ALZN
$5.06M
$6.22K ﹤0.01%
+8
New +$11.6K
STEX
479
Streamex Corp
STEX
$76.7M
$6.17K ﹤0.01%
+1,470
New +$7.26K
SIOX
480
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.05K ﹤0.01%
+13,913
New +$4.52K
VSTM icon
481
Verastem
VSTM
$532M
$6.04K ﹤0.01%
+1,249
New +$6.13K
OTMO
482
DELISTED
Otonomo Technologies Ltd. Ordinary shares
OTMO
$6.01K ﹤0.01%
984
+44
+5% +$237
MBIO icon
483
Mustang Bio
MBIO
$4.26M
$5.92K ﹤0.01%
+20
New +$6.83K
RTB
484
RTB Digital
RTB
$212M
$5.91K ﹤0.01%
37
+5
+16% +$1.41K
PLAOW
485
DELISTED
Patria Latin American Opportunity Acquisition Corp. Warrant
PLAOW
$5.84K ﹤0.01%
+64,900
New +$4.69K
CELZ icon
486
Creative Medical Technology
CELZ
$5.26M
$5.72K ﹤0.01%
+1,500
New +$6.17K
PDYN icon
487
Palladyne AI
PDYN
$233M
$5.71K ﹤0.01%
+1,697
New +$14.5K
BJDX icon
488
Bluejay Diagnostics
BJDX
$1.07M
– –
0
– –
ORTX
489
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$5.57K ﹤0.01%
+1,500
New +$6.63K
CRDL
490
Cardiol Therapeutics
CRDL
$136M
$5.4K ﹤0.01%
+10,586
New +$6.45K
MSDAW
491
DELISTED
MSD Acquisition Corp. Warrant
MSDAW
$5.39K ﹤0.01%
+69,600
New +$4.44K
GLMD icon
492
Galmed Pharmaceuticals
GLMD
$3.94M
$5.28K ﹤0.01%
+59
New +$3.86K
CPUH.WS
493
DELISTED
Compute Health Acquisition Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
CPUH.WS
$5.1K ﹤0.01%
+45,413
New +$4.92K
FABC
494
Fabric.AI Inc
FABC
$16.8M
$5.09K ﹤0.01%
104
+14
+16% +$981
CONXW
495
DELISTED
CONX Corp. Warrant
CONXW
$5.03K ﹤0.01%
+33,500
New +$5.52K
TNXP icon
496
Tonix Pharmaceuticals
TNXP
$157M
$4.96K ﹤0.01%
+1
New +$8.63K
AXLA
497
DELISTED
Axcella Health Inc. Common Stock
AXLA
$4.91K ﹤0.01%
+600
New +$15.5K
DNTH icon
498
Dianthus Therapeutics
DNTH
$5.68B
$4.83K ﹤0.01%
+765
New +$13.5K
VERO
499
DELISTED
Venus Concept
VERO
$4.8K ﹤0.01%
+91
New +$4.09K
ASPU
500
DELISTED
ASPEN GROUP, INC.
ASPU
$4.65K ﹤0.01%
15,000
+308
+2% +$112
18 19
20
21 22

Similar funds

CFA
Capstone Financial Advisors Downers Grove, Illinois $1.86B AUM 15.98% 1-Year Est. Return
OFG
Oxford Financial Group Carmel, Indiana $1.86B AUM 19.25% 1-Year Est. Return
JSAM
J. Safra Asset Management New York $1.86B AUM 22.95% 1-Year Est. Return
GRA
Goehring & Rozencwajg Associates New York $1.86B AUM 130.26% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
WRBC
W.R. Berkley Corp Greenwich, Connecticut $1.86B AUM 14.44% 1-Year Est. Return
ACM
American Capital Management New York $1.86B AUM 20.23% 1-Year Est. Return
EAM
Evanson Asset Management Carmel, California $1.86B AUM 25.39% 1-Year Est. Return

StoneX Group's Q4 2022 Portfolio in Review

As of Q4 2022, StoneX Group held 678 positions worth $687M, up 28% from $537M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

StoneX Group deployed $115M of net new capital in Q4 2022, opening 317 new positions and adding to 139 existing holdings. Its largest new stake was State Street SPDR S&P 500 ETF Trust: 7,758 shares worth $2.98M.

By sector, the portfolio is most concentrated in Healthcare at 1.9% of assets, up from 0.03% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Vanguard Mega Cap Growth ETF, an estimated $4.64M trimmed.

  • StoneX Group's largest Q4 2022 buy was State Street SPDR S&P 500 ETF Trust: 7,758 shares worth $2.98M.
  • StoneX Group added most to iShares Russell Mid-Cap ETF in Q4 2022, an estimated $12.3M increase.
  • StoneX Group's biggest Q4 2022 reduction was Vanguard Mega Cap Growth ETF, cutting an estimated $4.64M.
  • StoneX Group fully exited Lefteris Acquisition Corp. Class A Common Stock in Q4 2022, selling an estimated $2.17M.
  • StoneX Group's ten largest holdings make up 39% of its $687M portfolio in Q4 2022.
  • StoneX Group opened 317 new positions and closed 86 in Q4 2022.
  • StoneX Group's portfolio value rose 28% quarter-over-quarter to $687M.

Based on StoneX Group's 13F filing for Q4 2022, filed 10 Feb 2023.